Healthcare Software Compliance in 2026: What Changes Across the US, UK, EU and India

A healthcare product rarely stays in one country for long. A telemedicine app built for a US clinic network gets a request from a UK partner. A hospital system in India signs a pilot with a Gulf provider. Each move brings a new rulebook, and the cost of ignoring it shows up late, usually as rework.

This article gives a practical overview of the rules shaping healthcare software in 2026, and how to design for them from the start. It is general product-planning information, not legal advice, so confirm requirements with qualified counsel in each market.

Start with the strictest rule, not the first one

The most useful principle in multi-market compliance is simple: identify every jurisdiction your data touches before writing code, then design for the strictest one. A system built to the highest standard can usually be relaxed for a lighter market. A system built to the lowest standard has to be rebuilt.

Teams planning a build from scratch can see how this fits into scope, cost and process in Triazine’s guide to custom healthcare software development, which includes a market-by-market compliance table.

United States: three things to watch

HIPAA Security Rule changes are still proposed. HHS published its notice of proposed rulemaking on 6 January 2025. It would remove the “addressable” distinction for safeguards such as encryption and add requirements such as multi-factor authentication. It is not law yet, and final action dates on the federal agenda can move. The practical advice is to build to the proposed standard now, because the current rule already requires a thorough risk analysis.

FDA guidance on clinical decision support was updated in January 2026. Software that analyses medical images, or signals from diagnostic and other signal-acquisition devices, for a medical purpose generally stays under FDA device oversight. Some decision support and documentation tools can qualify as non-device software if they meet four statutory criteria, including letting the clinician independently review the basis of a recommendation. Classification depends on intended use, so confirm it before you fix your product scope.

CMS interoperability deadlines arrive on 1 January 2027. Under CMS-0057-F, impacted payers need FHIR-based APIs for patient access, provider access, payer-to-payer exchange and prior authorization. If you build for payers, or for providers who exchange data with them, this shapes your integration roadmap.

United Kingdom and European Union

In the UK, UK GDPR and the Data Protection Act 2018 apply, along with NHS assurance expectations. For product teams, that means a lawful basis for processing health data, data protection impact assessments and documented clinical safety practices.

The EU adds GDPR’s special-category rules for health data, the EU MDR for medical device software and the EU AI Act. The AI Act timeline has moved. Amendments that entered into force on 27 July 2026 pushed high-risk obligations to 2 December 2027 for stand-alone systems and 2 August 2028 for AI embedded in regulated products such as medical devices. Teams building AI features should track that calendar, and keep a clinician in the loop for anything that influences diagnosis or treatment.

India: DPDP Rules are phasing in

India notified the Digital Personal Data Protection Rules in November 2025, with an 18-month phased timeline. Counted from the Gazette publication date, the Consent Manager provisions begin on 14 November 2026, and the main obligations on data fiduciaries apply from 14 May 2027. Those cover consent, notice, security safeguards, breach notification and erasure. Some commentators count from the notification date instead, so confirm exact dates with your counsel.

Penalties can reach up to ₹250 crore, so this is not a paperwork exercise. For any platform that handles health data of Indian residents, consent management and erasure workflows should be designed now. Integration with national digital health infrastructure also brings ABDM standards into scope.

UAE, Australia and South Africa

The UAE combines a federal health data law with emirate-level regulator requirements, so health data residency and licensing are the first things to check. Australia’s Privacy Act 1988 treats health data as sensitive information, and My Health Record requirements apply when you integrate with it. South Africa’s POPIA classes health information as special personal information, which means stricter processing conditions and more careful consent design.

“HIPAA compliant” is not a product label

One misunderstanding causes a lot of trouble. Compliance is a shared responsibility between the covered entity or business associate, the hosting environment, configuration, policies, staff training and contracts. A development partner can implement safeguards and provide documentation. No vendor can guarantee compliance without reviewing how the product is deployed and used. Ask early who signs the Business Associate Agreement or data processing agreement, and what it covers.

The baseline every product should ship with

Whatever the market, a few controls are expected from day one:

• Encryption of data at rest and in transit

• Role-based access control, so users see only what their role requires

• Multi-factor authentication for anyone touching patient data

• Complete audit logging of who accessed or changed what

• Consent capture and management

• Secure APIs with rate limiting and input validation

• Regular vulnerability scanning and penetration testing

• Tested backup and disaster recovery

The stakes are real. IBM’s 2025 research put the average healthcare data breach at USD 7.42 million, the highest of any industry for the 14th year running. Embedding security tests into the delivery pipeline is what stops this from becoming a one-time exercise, which is the idea behind DevSecOps. Vulnerabilities found in a pipeline check cost a fraction of vulnerabilities found in production.

Privacy-heavy products need extra care

Some categories carry the highest privacy stakes, and mental health platforms are the clearest example. Secure one-to-one communication, practitioner networks and strict role-based access are core requirements, not extras. Triazine’s Lyfe by TTM case study shows how a mental health platform can be built with those requirements from the first release.

Putting it into practice

A workable plan for a multi-market healthcare product looks like this:

1. Map every data flow and the jurisdictions it touches.

2. Choose the strictest applicable standard as the design baseline.

3. Build consent, audit and access controls into the architecture.

4. Confirm product classification, such as FDA device status, early.

5. Track regulatory calendars for the HIPAA proposal, DPDP phases and the EU AI Act.

6. Work with a partner who can explain how each rule changes the design, not only the testing.

Teams that want to see how this works in practice can explore Triazine’s healthcare and digital health practice, which builds hospital systems, maternal care, community health, home care and mental health platforms for organisations across several regions.